Early combination therapy could translate into fewer downstream hospitalizations and lower costs associated with dialysis and cardiovascular complications.

The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast .

Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer, suggesting a possible ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Healthier people cost less. Figure out what could keep them well, and the government money spent on the discovery may well be ...

Diagnosed with melanoma skin cancer, John was originally told he had 12 months to live — but after pushing for further ...

Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...

Dr. Annu Navani stands at the forefront of innovation in clinical Orthobiologics and Longevity medicine. A triple-board certified physician in Anesthesiology, Pain Medicine, and Regenerative Medicine, ...

In yanking funding from mRNA vaccines, he says he’s listening to the experts. We asked some experts about that.

The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...

The renowned research hospital that cares for people with rare or life-threatening diseases has been pummeled by an employee ...

The University of Washington is offering new hope for people who have suffered a stroke by implanting a device directly in ...